Clia Laboratory Testing

With the internet’s seemingly easy access to (often false) healthcare information, people are taking less charge of their personal health. Facts on a screen never tell the full story. Blood tests are a necessary step in ensuring everyone stays in tip-top shape, preventing potential illness, infection, and even cancer. Since 1975, ACM Medical Laboratory has been Rochester, NY’s leader in preventive care, including all the lab and screening tests patients need to stay in top condition. Working with patients and healthcare providers alike, ACM develops customized healthcare solutions.

The Clinical Laboratory Improvement Amendments (CLIA) established a program to regulate any size and all “laboratories that test patient specimens to ensure the labs produce accurate and reliable test results”, CLIA was passed in 1988 to establish quality standards and regulations on all non-research laboratory test, and they must meet applicable Federal requirements and have a CLIA certificate to operate.

Now that I remain in the CLT program, it has actually opened my eyes to a complete different world of operating in the medical laboratory field. Having that chance to be more involved with the breakdown of the process of the clinical laboratory studies is astounding. I ‘am pleased to have prepared myself to travel beyond with a little in order to succeed with wealth of

Proper patient identification in hospitals has been an issue for many years, especially when it comes to blood specimen collection. Laboratory specimens being mislabeled are a everyday cause of harm to patients including repeat diagnostic procedures; repeat phlebotomy; delays in necessary surgical procedures; a performing unnecessary surgical procedures (Dunn and Moga, 2010). This is not only costly, but it is very stressing to patients and medical staff. The biggest concern is the possibility of making a fatal error when it comes to specimen collection. Without proper patient identification this risk increases substantially. Wallin, Sodberg, Van Guelpen, Stenlund, Grankvist, and Brulin (2009) state that critical errors in patient identification for blood testing occurs in up to one per 1000 specimens or procedures and misidentified specimens cause 160,000 adverse events every year in America.

Her procedure was performed by a physician in an outside department rather than the oncology advance practice providers. As a result, the physician performing the procedure did not have personal knowledge of the test required and was dependent on our providers to communicate this information. Had her procedure been performed at the bedside, the team would have likely been performed in the afternoon. This may have prompted further communication of the need of this test during bedside round with the attending or a second advance practice provider who would have likely done the

The College of American Pathologists or CAP is the accrediting organization for laboratory and testing personnel. CAP’s “accreditation process is so thorough, the Joint Commission [and CMS] accepts …their standards” in place of conducting their own survey of the hospital’s laboratory and personnel (Gartee, 2011, p. 47). This is because of the guidelines they follow to maintain their integrity and to remain the industry standard. In recent years, the “CAP [has] developed new check list” for continued improvements. Additionally, they are continuing to vet the requirements for the new next-generation sequencing or NGC-based test that is speeding laboratory procedures. So much so that the recent adoption of the new technology for clinical testing” was done prior to the new standards being approved (Aziz, et.al. 2015, p. 481).

Gloves snapping, needles pricking, and blood gushing are often thought of when it is time to have one’s blood tested for various reasons. With a patient’s anxiety already running high, the slightest mishap can have a serious aftermath. If the venipuncture was painful or left horrible bruises, the patient may think of the procedure negatively in the future. More importantly, it is the Phlebotomist’s responsibility to obtain quality blood specimens to produce the most accurate laboratory results. (Garza, 2010) The School of Allied Health states, “It is widely accepted that the quality of a laboratory test is only as good as the specimen that was obtained.” (Allied Health, 2014) For this reason, a Phlebotomist

According to the article, the economics of health care quality and medical errors, in 2008 medical errors costs the United States $19.5 billion. It goes without saying that this a huge problem. It’s relieving to know that we are aware of several adverse detection (AE) methods such as voluntary or incident reporting, medical record review, administrative surveillance, clinical observation, and electronic health record surveillance. Voluntary reporting is the most common but unreliable way of detecting adverse events. It depends on the physician reporting and admitting that an adverse outcome as occurred. However, it has been shown to underestimate adverse events by a factor of 50 and often identifies issues other than true safety

In conclusion, I feel that the states should have licensure for laboratory scientist if they choose to work in a clinical laboratory. The arguments for outweigh the arguments against state licensure as well as both ASCLS and ASCP are in support of such action. The laboratory field has a broad range of option for a laboratory scientist to choose with options in research, clinical or even forensic with each having a different impact on the public. The clinical laboratory has the most the most immediate impact on the health of people in the community making the people working in those laboratories responsible for accuracy and quality of the patient testing. I explained that difference between certification and licensure is that the licensure was

This paper will discuss previous and current reimbursement rates for molecular laboratory testing and the effects these changes have on current and future laboratory economics. Clinical laboratory reimbursement rates have been decreasing since the 80s (Panning, 2014, p.122). Despite lower reimbursement rates, costs for performing these tests have increased. Some methods, such as point-of-care testing (POCT), have been implemented in molecular testing sites as well as in other sections of the lab, helping to reduce costs. Reduced reimbursement rates for molecular testing negatively impacts the economical structure of clinical laboratories.

This scientific report is about how much mass is lost in metals after being placed in 1 molar hydrochloric acid for 30 minutes. Tin, iron and zinc will be weighed and placed into test tubes which will then be filled with 1 molar hydrochloric acid. After 30 minutes the metals will be taken out and weighed again. It is expected that the more reaction that occurs, the more mass is lost. Tin is a metal and has many uses and is commonly used to coat other metals to prevent them from corroding. An example of this is in tin cans made of tin-coated steel. Iron is another common metal which rusts easily but it is very important as it is used to manufacture steel. Zinc is a metal which is most commonly used to galvanise metals

The preanalytical errors increases health care costs and decreases the patient satisfaction. The laboratory errors that happen at any stage of the total testing process have influence on quality of laboratory services. Any errors that happen during this total testing process will affect the patient care that also includes unnecessary recollection of samples, delay in reporting, misdiagnosis and treatment by the clinician. Although the errors can happen at any stage of the total testing process, preanalytical errors accounts for highest percentage (70%). The consequences associated with analytical errors are significantly reduced by the use of modern laboratory instruments. But pre analytical phase is still prone to more errors due to its complexity and different stages that involved within and outside laboratory. The inaccurate reporting of results due to preanalytical errors leads to unnecessary investigations and creating an additional burden to the healthcare system (Kaushik, & Green, 2014). According to Green (2013) the healthcare economist created a model to quantify the costs associated with laboratory errors and poor sample quality. It is based on operating costs, number of beds, test volume, number of rejected samples, instrument problems and the frequency of inaccurate results reported by laboratory and their impacts. As per this model

Errors in medicine are unfortunately plentiful, and are also oftentimes preventable. Even with technology, regulations, and procedures designed to improve health care and reduce errors, the occurrences are still much too high. Recent statistics from the World Health Organization show that 10% of hospitalized patients are harmed during their stay, and 1.4 million people at any time are suffering from hospital-acquired infections. It is estimated that when it comes to surgical care, 50% of associated complications are preventable (WHO). There are always ways to improve how tasks are performed in hospitals, and studying recent incidents can help us

College of American Pathologists (CAP) accreditation helps laboratories meet Clinical Laboratory Improvement Amendments (CLIA) regulatory requirements and certifies compliance through the guidance a complete list of the most recent clinical and laboratory standards. By doing this it ensures accuracy of lab results and maintains correct patient diagnosis. This increases the value of the laboratory. The CAP accreditation program is based on peer based inspections that use working laboratory professionals who are qualified through a CAP training program. It is the responsibility of the laboratory supervisors, managers, and directors to attend this training and participate in the CAP accreditation process.

Patient demographics (full name, date of birth, emergency contact information, next of kin, employer information etc...)